Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin Vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome

Overview

Journal Metabolites

Publisher MDPI

Date 2023 Jun 27

PMID 37367875

Authors

Zdravko Kamenov

Antoaneta Gateva

Simona Dinicola

Vittorio Unfer

Affiliations

Soon will be listed here.

Abstract

Despite the beneficial effect of myo-inositol on metabolic, hormonal, and reproductive parameters of polycystic ovary syndrome (PCOS) patients, 28% to 38% could be resistant to this treatment. The combination with the milk protein α-lactalbumin can be a useful therapeutic approach to overcome inositol resistance and achieve ovulation in these women. This open-label prospective study aimed to compare the effects of supplementing myo-inositol plus α-lactalbumin vs myo-inositol alone on reproductive and metabolic abnormalities in PCOS. A total of 50 anovulatory women with a PCOS diagnosis were randomly assigned to receive myo-inositol alone or a combination of myo-inositol and α-lactalbumin for three months. Anthropometric measures, hormonal levels, and menstrual cycle duration were collected at baseline and after treatment. The therapy with myo-inositol plus α-lactalbumin improved both ovulation rate and menstrual cycle duration more than myo-inositol alone. The body weight was significantly reduced in women receiving myo-inositol plus α-lactalbumin, while patients in the myo-inositol group experienced no change. In addition, the improvement of hyperandrogenism was more prominent in patients treated with myo-inositol plus α-lactalbumin. The benefits of associating myo-inositol and α-lactalbumin clearly make this combination a true edge in the management of PCOS.

Citing Articles

Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study.

Pezza M, Carlomagno V, Sammarco E, Trischitta A, Ceddia C, Vitiello A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006064 PMC: 11859446. DOI: 10.3390/ph18020251.

Disclosing α-lactalbumin impact on the intestinal and vaginal microbiota of women suffering from polycystic ovary syndrome.

Alessandri G, Mancabelli L, Fontana F, Lepore E, Forte G, Burratti M Microb Biotechnol. 2024; 17(10):e14540.

PMID: 39364592 PMC: 11450379. DOI: 10.1111/1751-7915.14540.

Deciphering Microbiome, Transcriptome, and Metabolic Interactions in the Presence of Probiotic against Typhimurium in a Murine Model.

Junaid M, Lu H, Din A, Yu B, Liu Y, Li Y Antibiotics (Basel). 2024; 13(4).

PMID: 38667028 PMC: 11047355. DOI: 10.3390/antibiotics13040352.

Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects.

Zhou M, Yu J, Li X, Ruan Z, Yu S J Cell Mol Med. 2024; 28(8):e18258.

PMID: 38546608 PMC: 10977384. DOI: 10.1111/jcmm.18258.

Combined Inositols, α-Lactalbumin, Gymnema Sylvestre and Zinc Improve the Lipid Metabolic Profile of Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial.

Nani A, Bertuzzi F, Meneghini E, Mion E, Pintaudi B J Clin Med. 2023; 12(24).

PMID: 38137721 PMC: 10743679. DOI: 10.3390/jcm12247650.

References

Matsuda M, Tsutsumi K, Kanematsu T, Fukami K, Terada Y, Takenawa T . Involvement of phospholipase C-related inactive protein in the mouse reproductive system through the regulation of gonadotropin levels. Biol Reprod. 2009; 81(4):681-9. DOI: 10.1095/biolreprod.109.076760. View

Morgante G, Orvieto R, Di Sabatino A, Musacchio M, De Leo V . The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. Fertil Steril. 2011; 95(8):2642-4. DOI: 10.1016/j.fertnstert.2011.01.035. View

Wernimont S, Northington R, Kullen M, Yao M, Bettler J . Effect of an α-lactalbumin-enriched infant formula supplemented with oligofructose on fecal microbiota, stool characteristics, and hydration status: a randomized, double-blind, controlled trial. Clin Pediatr (Phila). 2014; 54(4):359-70. PMC: 4370932. DOI: 10.1177/0009922814553433. View

Davis A, Harris B, Lien E, Pramuk K, Trabulsi J . Alpha-lactalbumin-rich infant formula fed to healthy term infants in a multicenter study: plasma essential amino acids and gastrointestinal tolerance. Eur J Clin Nutr. 2007; 62(11):1294-301. DOI: 10.1038/sj.ejcn.1602848. View

Papaleo E, Unfer V, Baillargeon J, De Santis L, Fusi F, Brigante C . Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol. 2007; 23(12):700-3. DOI: 10.1080/09513590701672405. View

Barber T, Dimitriadis G, Andreou A, Franks S . Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond). 2015; 15 Suppl 6:s72-6. DOI: 10.7861/clinmedicine.15-6-s72. View

Vrieze A, Holleman F, Zoetendal E, de Vos W, Hoekstra J, Nieuwdorp M . The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia. 2010; 53(4):606-13. PMC: 2830587. DOI: 10.1007/s00125-010-1662-7. View

Gerli S, Mignosa M, Di Renzo G . Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2004; 7(6):151-9. View

Huang L, Fonteles M, Houston D, Zhang C, Larner J . Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology. 1993; 132(2):652-7. DOI: 10.1210/endo.132.2.8425485. View

10.

Chiu T, Rogers M, Briton-Jones C, Haines C . Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod. 2003; 18(2):408-16. DOI: 10.1093/humrep/deg113. View

11.

Gambioli R, Forte G, Buzzaccarini G, Unfer V, Lagana A . Myo-Inositol as a Key Supporter of Fertility and Physiological Gestation. Pharmaceuticals (Basel). 2021; 14(6). PMC: 8227031. DOI: 10.3390/ph14060504. View

12.

Zacche M, Caputo L, Filippis S, Zacche G, Dindelli M, Ferrari A . Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocrinol. 2009; 25(8):508-13. DOI: 10.1080/09513590903015544. View

13.

Yamaguchi M, Takai S . Chronic administration of bovine milk-derived α-lactalbumin improves glucose tolerance via enhancement of adiponectin in Goto-Kakizaki rats with type 2 diabetes. Biol Pharm Bull. 2014; 37(3):404-8. DOI: 10.1248/bpb.b13-00762. View

14.

Unfer V, Facchinetti F, Orru B, Giordani B, Nestler J . Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017; 6(8):647-658. PMC: 5655679. DOI: 10.1530/EC-17-0243. View

15.

Genazzani A, Lanzoni C, Ricchieri F, Jasonni V . Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008; 24(3):139-44. DOI: 10.1080/09513590801893232. View

16.

Iuorno M, Jakubowicz D, Baillargeon J, Dillon P, Gunn R, Allan G . Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract. 2004; 8(6):417-23. DOI: 10.4158/EP.8.6.417. View

17.

Yamaguchi M, Yoshida K, Uchida M . Novel functions of bovine milk-derived alpha-lactalbumin: anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholipase A2. Biol Pharm Bull. 2009; 32(3):366-71. DOI: 10.1248/bpb.32.366. View

18.

Torres P, Siakowska M, Banaszewska B, Pawelczyk L, Duleba A, Kelley S . Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism. J Clin Endocrinol Metab. 2018; 103(4):1502-1511. PMC: 6276580. DOI: 10.1210/jc.2017-02153. View

19.

DAnna R, Corrado F, Loddo S, Gullo G, Giunta L, Di Benedetto A . Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. Sci Rep. 2021; 11(1):8866. PMC: 8065046. DOI: 10.1038/s41598-021-88329-x. View

20.

Papaleo E, Unfer V, Baillargeon J, Fusi F, Occhi F, De Santis L . RETRACTED: Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2008; 91(5):1750-1754. DOI: 10.1016/j.fertnstert.2008.01.088. View